Cost price drugs for developing countries are found in Belgian pharmaciesBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7368.794 (Published 12 October 2002) Cite this as: BMJ 2002;325:794
- Owen Dyer
The pharmaceutical industry's programme of sending HIV/AIDS drugs to Africa at preferential prices has been undermined by unscrupulous traders reimporting the cheap drugs to Europe for sale at full price, it emerged last week.
An investigation by Belgian customs authorities found that at least three million doses of GlaxoSmithKline's Combivir (zidovudine)—earmarked for sale in Africa at about £0.50 (€ 0.80; $0.78) per dose—have found their way onto European pharmacists' shelves, where they sell for about £3.80 (£6.00; $5.94) per dose. Quantities of GlaxoSmithKline's antiretroviral drugs Epivir (lamivudine) and Trizivir (abacavir) have also been illegally diverted back to Europe.
The drugs were supposed to go to HIV/AIDS …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial